S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
NASDAQ:SRPT

Sarepta Therapeutics Short Interest Ratio and Short Volume

$78.50
-4.69 (-5.64%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$76.23
$83.39
50-Day Range
$77.28
$99.42
52-Week Range
$65.30
$181.83
Volume
1.72 million shs
Average Volume
1.30 million shs
Market Capitalization
$6.84 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.21

Sarepta Therapeutics (NASDAQ:SRPT) Short Interest Data

Current Short Volume
4,680,000 shares
Previous Short Volume
4,590,000 shares
Change Vs. Previous Month
+1.96%
Dollar Volume Sold Short
$392.56 million
Short Interest Ratio / Days to Cover
4.7
Last Record Date
November, 15 2021
Outstanding Shares
87,077,000 shares
Percentage of Shares Shorted
5.37%
Today's Trading Volume
1,721,933 shares
Average Trading Volume
1,304,880 shares
Today's Volume Vs. Average
31.96%
Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Sarepta Therapeutics ?

Sign up to receive the latest short interest report for Sarepta Therapeutics and its competitors with MarketBeat's FREE newsletter.

Sarepta Therapeutics (NASDAQ:SRPT) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/20214,680,000 shares $392.56 million +2.0%N/A4.7 $83.88
10/29/20214,590,000 shares $363.21 million -8.8%N/A4.7 $79.13
10/15/20215,030,000 shares $423.48 million -0.2%N/A5.3 $84.19
9/30/20215,040,000 shares $466.10 million -11.0%6.7%6 $92.48
9/15/20215,660,000 shares $475.72 million -3.6%7.5%7.3 $84.05
8/31/20215,870,000 shares $458.56 million -5.0%7.8%7.5 $78.12
8/13/20216,180,000 shares $494.03 million -2.4%8.2%6.7 $79.94
7/30/20216,330,000 shares $429.05 million -2.5%8.3%6 $67.78
7/15/20216,490,000 shares $443.72 million +0.8%8.5%5.9 $68.37
6/30/20216,440,000 shares $500.65 million -3.3%8.5%5.9 $77.74
6/15/20216,660,000 shares $553.71 million -16.7%8.8%5.8 $83.14
5/28/20217,990,000 shares $604.44 million +4.0%10.5%6.9 $75.65
5/14/20217,680,000 shares $556.88 million +8.0%N/A6.6 $72.51
4/30/20217,110,000 shares $507.73 million -2.2%N/A6.3 $71.41
4/15/20217,270,000 shares $533.84 million -0.7%N/A6.3 $73.43
3/31/20217,320,000 shares $535.09 million +7.3%N/A3.5 $73.10
3/15/20216,820,000 shares $589.73 million -6.8%N/A3.3 $86.47
2/26/20217,320,000 shares $624.03 million +8.9%N/A3.6 $85.25
2/12/20216,720,000 shares $609.97 million -13.3%N/A3.6 $90.77
1/29/20217,750,000 shares $698.51 million -4.3%N/A4.1 $90.13
1/15/20218,100,000 shares $728.19 million +14.6%N/A4.6 $89.90
12/31/20207,070,000 shares $1.21 billion -10.6%N/A5 $171.54
12/15/20207,910,000 shares $1.34 billion -9.1%N/A11.3 $169.54
11/30/20208,700,000 shares $1.21 billion +5.2%N/A12.7 $139.15
11/15/20208,270,000 shares $1.17 billion -6.2%N/A11.6 $141.40

Institutional Investors Shorting Sarepta Therapeutics (NASDAQ:SRPT)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of Sarepta Therapeutics. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
12/1/2021Balyasny Asset Management LLCN/A62,000N/A$5.73 thousand
11/16/2021Jane Street Group LLC62,20064,900+4.3%$6.00 thousand
11/16/2021Citadel Advisors LLC202,100166,800-17.5%$15.43 thousand
11/15/2021Balyasny Asset Management LLCN/A62,000N/A$5.73 thousand
11/15/2021Caas Capital Management LP143,000143,000No Change$13.23 thousand
11/15/2021DLD Asset Management LP10,0000-100.0%$0.00
11/12/2021Wolverine Asset Management LLC112,400225,400+100.5%$20.84 thousand
11/12/2021Credit Suisse AG61,20050,300-17.8%$4.65 thousand
11/12/2021Cowen AND Company LLCN/A3,700N/A$32.00
11/12/2021Wolverine Trading LLC25,40025,500+0.4%$2.26 thousand
11/10/2021Goldman Sachs Group Inc.22,60022,600No Change$2.09 thousand
11/10/2021HAP Trading LLCN/A15,900N/A$105.00
11/9/2021Barclays PLCN/A5,800N/A$536.00
11/9/2021Concourse Financial Group Securities Inc.N/A0N/A$0.00
11/5/2021IMC Chicago LLC34,00030,100-11.5%$2.78 thousand













Sarepta Therapeutics (NASDAQ:SRPT) Short Interest Frequently Asked Questions

What is Sarepta Therapeutics' current short interest?

Short interest is the volume of Sarepta Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 4,680,000 shares of SRPT short. Learn More on Sarepta Therapeutics' current short interest.

What is a good short interest ratio for Sarepta Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Sarepta Therapeutics currently has a short interest ratio of 5.0. Learn More on a good short interest ratio for Sarepta Therapeutics

Which institutional investors are shorting Sarepta Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Sarepta Therapeutics: Balyasny Asset Management LLC, Jane Street Group LLC, Citadel Advisors LLC, Balyasny Asset Management LLC, Caas Capital Management LP, DLD Asset Management LP, Wolverine Asset Management LLC, Credit Suisse AG, Cowen AND Company LLC, Wolverine Trading LLC, Goldman Sachs Group Inc., HAP Trading LLC, Barclays PLC, Concourse Financial Group Securities Inc., and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Sarepta Therapeutics' short interest increasing or decreasing?

Sarepta Therapeutics saw a increase in short interest in November. As of November 15th, there was short interest totaling 4,680,000 shares, an increase of 2.0% from the previous total of 4,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Sarepta Therapeutics' short interest compare to its competitors?

0.00% of Sarepta Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Sarepta Therapeutics: Genmab A/S (0.00%), Genmab A/S (0.00%), Shiseido Company, Limited (0.00%), Royalty Pharma plc (1.94%), Horizon Therapeutics Public Limited (2.70%), UCB SA (0.00%), Catalent, Inc. (0.00%), Alnylam Pharmaceuticals, Inc. (0.00%), BioMarin Pharmaceutical Inc. (5.57%), and Viatris Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Railway Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short Sarepta Therapeutics stock?

Short selling SRPT is an investing strategy that aims to generate trading profit from Sarepta Therapeutics as its price is falling. Sarepta Therapeutics' stock is trading down $4.69 today. To short Sarepta Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Sarepta Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sarepta Therapeutics?

A short squeeze for Sarepta Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SRPT, which in turn drives the price of the stock up even further.

How often is Sarepta Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SRPT, twice per month. The most recent reporting period available is November, 15 2021.



This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.